ASA Comments on Recently Revealed DOJ Memo on Rohrabacher-Farr CJS Amendment

On Wednesday, Tom Angell chairman of Marijuana Majority scored a big scoop revealing for the first time the Department of Justice’s detailed response to the Rohrabacher-Farr Medical Cannabis Amendment.

Sadly, if not completely surprisingly,  the DOJ argues that federal prosecutions against private citizens participating in state-level medical cannabis programs would not be impacted by the amendment. DOJ also appears to admit to providing misleading information to Congress ahead of last year’s vote on Rohrabacher-Farr.

ASA Government Affairs Director Mike Liszewski issued the following comment:

The February 27, 2015 DOJ memo shows that they were providing either deliberately misleading statements or, at the very least, contradictory and confusing messages in their talking points in…